The Global Health Body Sounds Concern Over Severe Shortage of Obesity Jabs

Less than 10% of patients eligible to benefit from weight-loss injections like Wegovy are able to get them, warns the World Health Organization as it issues its initial guidance on the therapies.

With in excess of 1,000,000,000 individuals worldwide currently obese, it is advocating for more widespread and fairer access to these injectable treatments.

Based on projections, more than two billion will be living with obesity by 2030 unless action is taken.

"The latest guidelines acknowledges that obesity is a long-term condition that can be managed with holistic and continuous care," remarked WHO director-general Tedros Adhanom Ghebreyesus.

Substantial prices, limited production capacity, and distribution challenges are key hurdles to broad availability to the treatments that can aid individuals in losing significant body mass, says the organization.

GLP-1 Therapy Supply Crisis

Even in the current most favorable scenario, the supply of these medications would only suffice for about 100 million people – under 10% of those who need them, per the health organization.

The guideline encourages countries and companies to widen access, through approaches like licensing agreements.

Exclusive production rights on a key compound – the main component of Novo Nordisk's Wegovy – is set to lapse in multiple nations in 2026.

The Way Obesity Drugs Function

The injections mimick a biological compound to delay gastric emptying, curb appetite and enhance the sense of being full so individuals reduce food intake.

Individuals commonly begin shedding pounds after several weeks of beginning the once-weekly jabs.

Evidence indicates people may regain a significant portion within a year of stopping the drug, when their usual hunger resume.

To be overweight or obese raises your risk for contracting health problems, including type 2 diabetes, cardiovascular issues, brain attack, and specific cancers.

Obesity affects individuals in every country and was responsible for over three and a half million deaths worldwide in 2024, as per the WHO.

Brent Mcbride MD
Brent Mcbride MD

Elena is an interior design expert with a passion for minimalist aesthetics and sustainable home solutions.